- Home
- About
- Resource Library
- Mental Health Disorders
- Agitation
- Anxiety Disorders
- Bipolar Disorder
- Cognition
- Depression
- Eating Disorders
- Personality Disorders
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Neuroscience
- Payer & Financing Models
- Quality Standards & Performance Measures
- Stigma
- Suicide Awareness
- Wellness
- Collections
- Featured
- Monthly Spotlight
- Psychopharmacology
- Learning Tracks
- Community Insights
- Community Podcast
- Disease Management & Support Tools
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Patient & Caregiver Resource Center
- PsychU Roleplay
- Psychiatric Scales
- PsychUSim
- Events
Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A
Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A
The presenters will discuss the history of psychedelics in therapeutic approaches with a primary focus on psilocybin. They will also review the neurobiology of psychedelics and the role of 5-HT2A receptors, review the results of recently published findings, and discuss the challenges associated with psychedelic-assisted therapies.
Featuring
-
Jessie Chambers, PhD (OPDC)
Senior Clinical & Scientific Liaison
-
Dennis Sholler, PhD (OPDC)
Clinical & Scientific Liaison
-
Amica Simmons-Yon, PharmD, PhD (OPDC)
Clinical & Scientific Liaison
Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
-
Virtual Event – Monoamine Theory In Depression: Implications For Disease & Treatment
June 3 12:00 pm to 1:00 pm
Register
This event registration is closed.
Related Events
-
Virtual Event – Monoamine Theory In Depression: Implications For Disease & Treatment
June 3 12:00 pm to 1:00 pm
Stay Connected:
- Resource Library